DHEA Formulations and Routes of Administration
DHEA is primarily available as oral tablets or capsules (typically 25-50 mg doses), with additional formulations including transdermal creams/gels (10% concentration), intravaginal preparations, and homeopathic liquid drops.
Available Dosage Forms
Oral Formulations
The most commonly used and guideline-recommended form is oral DHEA tablets or capsules 1. Standard dosing ranges from 25-50 mg as a single daily dose, typically taken in the morning 1, 2. The Endocrine Society guidelines specifically recommend oral DHEA at 25-50 mg daily for women with primary adrenal insufficiency experiencing low libido, depressive symptoms, or low energy despite optimized glucocorticoid and mineralocorticoid replacement 1.
Transdermal Preparations
Transdermal DHEA is available as creams or gels at 10% concentration 3, 4. Research demonstrates that 4 grams of 10% DHEA cream or gel applied to a 30 cm x 30 cm surface area (typically the thighs) provides systemic absorption 3. The percutaneous route avoids first-pass hepatic metabolism, resulting in more stable 24-hour serum levels compared to oral administration 3.
Intravaginal Formulations
Intravaginal DHEA has been studied for genitourinary syndrome of menopause, though guidelines note insufficient safety data for women with breast cancer history 5. This route provides local tissue effects with minimal systemic absorption.
Homeopathic Preparations
FDA-labeled homeopathic formulations exist as liquid drops containing DHEA 6X along with other ingredients, administered sublingually 6. However, these highly diluted preparations lack the clinical evidence supporting standard pharmaceutical doses.
Route-Specific Considerations
Oral vs. Transdermal Metabolism
A critical distinction exists between routes: oral DHEA undergoes extensive first-pass metabolism in the gastrointestinal tract and liver, producing higher levels of metabolites (DHEA-sulfate, androsterone glucuronide, androstane-3α,17β-diol-G) compared to transdermal administration 3. Transdermal application maintains more consistent serum DHEA levels throughout the 24-hour period without the peaks and troughs seen with oral dosing 3.
Research shows that serum DHEA levels do not accurately reflect tissue-level androgenic and estrogenic activity because DHEA acts primarily through intracrine conversion to active steroids within target tissues, with minimal release into circulation 4. The conjugated metabolites of dihydrotestosterone serve as more reliable markers of total androgen pool activity 4.
Clinical Monitoring
Regardless of formulation, monitoring should include morning serum DHEAS levels (before the daily dose) aiming for the mid-normal range 1. Treatment trials should last 6 months, with discontinuation if no sustained benefit is observed 1.
Important Caveats
- DHEA is available over-the-counter or via internet in many countries, leading to unregulated use despite limited long-term safety data 1
- Oral administration at 25 mg daily increases androgenic, estrogenic, and progestogenic parameters in postmenopausal women 7
- The evidence for routine DHEA supplementation remains insufficient, with systematic reviews showing inconsistent clinical benefits 1
- Intravaginal DHEA is not currently recommended for women with breast cancer history due to inadequate safety data 5